http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109891237-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-62 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate | 2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109891237-B |
titleOfInvention | Bioassays for Insulin Preparations |
abstract | The present invention relates to a bioassay of insulin peptides in oral formulations and low affinity insulin peptides in liquid formulations by quantifying phosphorylated Akt, thereby avoiding the interference of excipients in potency determination. |
priorityDate | 2016-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.